| 13 | RVMD | REVOLUTION MEDICINES INC | $1.3B | 13.6M shares | 7.5% | before Q2 2023 |
| 14 | AON | AON PLC-CLASS A | $811M | 2.5M shares | 4.6% | before Q2 2023 |
| 15 | BBIO | BRIDGEBIO PHARMA INC | $695.5M | 9.4M shares | 4.0% | Q4 2023 |
| 16 | PTGX | PROTAGONIST THERAPEUTICS INC | $669.2M | 6.3M shares | 3.8% | before Q2 2023 |
| 17 | NTRA | NATERA INC | $641.4M | 3.2M shares | 3.7% | before Q2 2023 |
| 18 | EXEL | EXELIXIS INC | $562.3M | 13.1M shares | 3.2% | before Q2 2023 |
| 19 | UNH | UNITEDHEALTH GROUP INC | $492.9M | 1.8M shares | 2.8% | before Q2 2023 |
| 20 | BSX | BOSTON SCIENTIFIC CORP | $468.8M | 7.5M shares | 2.7% | before Q2 2023 |
| 21 | TMO | THERMO FISHER SCIENTIFIC INC | $433.3M | 881.5K shares | 2.5% | before Q2 2023 |
| 22 | KKR | KKR & CO INC | $432.1M | 4.7M shares | 2.5% | Q4 2025 |
| 23 | LNTH | LANTHEUS HOLDINGS INC | $423.5M | 5.6M shares | 2.4% | before Q2 2023 |
| 24 | WAB | WABTEC CORP | $402.2M | 1.6M shares | 2.3% | before Q2 2023 |
| 25 | SCHW | SCHWAB (CHARLES) CORP | $371.8M | 4M shares | 2.1% | Q4 2024 |
| 26 | LQDA | LIQUIDIA CORP | $326.7M | 8.7M shares | 1.9% | Q1 2024 |
| 27 | CRNX | CRINETICS PHARMACEUTICALS IN | $302.8M | 8.3M shares | 1.7% | Q3 2023 |
| 28 | ROIV | ROIVANT SCIENCES LTD | $268M | 9.7M shares | 1.5% | before Q2 2023 |
| 29 | V | VISA INC-CLASS A SHARES | $254.1M | 840.7K shares | 1.4% | before Q2 2023 |
| 30 | ARMK | ARAMARK | $248.7M | 6.1M shares | 1.4% | before Q2 2023 |
| 31 | BEAM | BEAM THERAPEUTICS INC | $241.5M | 10.1M shares | 1.4% | before Q2 2023 |
| 32 | DIS | WALT DISNEY CO/THE | $231.5M | 2.4M shares | 1.3% | Q2 2024 |
| 33 | MA | MASTERCARD INC - A | $217.4M | 435.1K shares | 1.2% | before Q2 2023 |
| 34 | MCK | MCKESSON CORP | $202.8M | 234.3K shares | 1.2% | Q4 2024 |
| 35 | AGIO | AGIOS PHARMACEUTICALS INC | $192.3M | 5.7M shares | 1.1% | before Q2 2023 |
| 36 | CUSIP:152309100 | CENTESSA PHARMACEUTICALS PLC | $191M | 4.8M shares | 1.1% | Q1 2024 |
| 37 | TNGX | TANGO THERAPEUTICS INC | $190.3M | 9.1M shares | 1.1% | Q4 2024 |
| 38 | GRAL | GRAIL INC | $168.2M | 3.3M shares | 1.0% | Q2 2025 |
| 39 | TYRA | TYRA BIOSCIENCES INC | $137.1M | 3.6M shares | 0.8% | Q4 2024 |
| 40 | THC | TENET HEALTHCARE CORP | $85.3M | 452.2K shares | 0.5% | before Q2 2023 |
| 41 | CAH | CARDINAL HEALTH INC | $77.8M | 368K shares | 0.4% | Q1 2025 |
| 42 | PCVX | VAXCYTE INC | $73.3M | 1.3M shares | 0.4% | Q4 2023 |
| 43 | DNTH | DIANTHUS THERAPEUTICS INC | $70.2M | 836K shares | 0.4% | Q1 2026 |
| 44 | BTSG | BRIGHTSPRING HEALTH SERVICES | $68.9M | 1.6M shares | 0.4% | Q1 2024 |
| 45 | TWST | TWIST BIOSCIENCE CORP | $67.8M | 1.4M shares | 0.4% | Q2 2024 |
| 46 | CGON | CG ONCOLOGY INC | $45.6M | 674K shares | 0.3% | Q2 2025 |
| 47 | AZN | ASTRAZENECA PLC | $44.7M | 226.5K shares | 0.3% | Q1 2026 |
| 48 | CUSIP:90138AAE3 | VNET GROUP INC | $44.5M | 45M shares | 0.3% | Q1 2026 |
| 49 | MRK | MERCK & CO. INC. | $43.4M | 361K shares | 0.2% | Q1 2026 |
| 50 | ACHC | ACADIA HEALTHCARE CO INC | $40.6M | 1.7M shares | 0.2% | Q4 2023 |
| 51 | WELL | WELLTOWER INC | $39.5M | 200K shares | 0.2% | Q4 2025 |
| 52 | IMVT | IMMUNOVANT INC | $38.4M | 1.5M shares | 0.2% | Q3 2023 |
| 53 | ENTA | ENANTA PHARMACEUTICALS INC | $36.3M | 2.9M shares | 0.2% | before Q2 2023 |
| 54 | JNJ | JOHNSON & JOHNSON | $36.2M | 148K shares | 0.2% | Q1 2026 |
| 55 | BBNX | BETA BIONICS INC | $36.2M | 3.6M shares | 0.2% | Q1 2025 |
| 56 | ASMB | ASSEMBLY BIOSCIENCES INC | $34.1M | 1.2M shares | 0.2% | Q3 2025 |
| 57 | JOYY | JOYY INC-ADR | $33.8M | 578.2K shares | 0.2% | Q1 2025 |
| 58 | CUSIP:594972AS0 | STRATEGY INC | $32.9M | 39.5M shares | 0.2% | Q1 2026 |
| 59 | NTES | NETEASE INC-ADR | $32.6M | 291.2K shares | 0.2% | Q1 2026 |
| 60 | NVO | NOVO-NORDISK A/S-SPONS ADR | $28.7M | 782K shares | 0.2% | Q1 2026 |
| 61 | BITW | BITWISE 10 CRYPTO INDEX ETF | $26.9M | 603K shares | 0.2% | Q4 2025 |
| 62 | PCSC | PERCEPTIVE CAPITAL SOLUTIONS | $24.7M | 2.3M shares | 0.1% | Q4 2025 |
| 63 | RPRX | ROYALTY PHARMA PLC- CL A | $23.6M | 493K shares | 0.1% | Q1 2026 |
| 64 | NERV | MINERVA NEUROSCIENCES INC | $14.2M | 2.4M shares | 0.1% | Q4 2025 |
| 65 | CECO | CECO ENVIRONMENTAL CORP | $13.9M | 234K shares | 0.1% | Q1 2026 |
| 66 | AVTX | AVALO THERAPEUTICS INC | $13.7M | 916K shares | 0.1% | Q1 2026 |
| 67 | GDS | GDS HOLDINGS LTD - ADR | $11.8M | 292K shares | 0.1% | Q1 2024 |
| 68 | MAZE | MAZE THERAPEUTICS INC | $11.1M | 373K shares | 0.1% | Q1 2026 |
| 69 | TEVA | TEVA PHARMACEUTICAL-SP ADR | $10.7M | 354K shares | 0.1% | Q3 2025 |
| 70 | FORM | FORMFACTOR INC | $5.5M | 56.5K shares | 0.0% | Q1 2026 |
| 71 | MTZ | MASTEC INC | $5.5M | 17K shares | 0.0% | Q1 2026 |
| 72 | C | CITIGROUP INC | $5.3M | 47K shares | 0.0% | Q1 2026 |
| 73 | H | HYATT HOTELS CORP - CL A | $5.2M | 36K shares | 0.0% | Q1 2026 |
| 74 | WAL | WESTERN ALLIANCE BANCORP | $5.2M | 73K shares | 0.0% | Q1 2026 |
| 75 | TKR | TIMKEN CO | $5.1M | 51K shares | 0.0% | Q1 2026 |
| 76 | FLEX | FLEX LTD | $5.1M | 78K shares | 0.0% | Q1 2026 |
| 77 | SPGI | S&P GLOBAL INC | $5.1M | 12K shares | 0.0% | before Q2 2023 |
| 78 | LFUS | LITTELFUSE INC | $5.1M | 15K shares | 0.0% | Q1 2026 |
| 79 | PIPR | PIPER SANDLER COS | $5.1M | 66K shares | 0.0% | Q1 2026 |
| 80 | AIR | AAR CORP | $5M | 46K shares | 0.0% | Q1 2026 |
| 81 | RIO | RIO TINTO PLC-SPON ADR | $5M | 53.8K shares | 0.0% | before Q2 2023 |
| 82 | GTX | GARRETT MOTION INC | $5M | 275K shares | 0.0% | Q1 2026 |
| 83 | ROL | ROLLINS INC | $5M | 93K shares | 0.0% | Q1 2026 |
| 84 | AFRM | AFFIRM HOLDINGS INC | $4.9M | 108K shares | 0.0% | Q1 2026 |
| 85 | INTR | INTER & CO INC - CL A | $4.9M | 614.5K shares | 0.0% | Q1 2026 |
| 86 | CMI | CUMMINS INC | $4.8M | 9K shares | 0.0% | Q1 2026 |
| 87 | FISV | FISERV INC | $4.8M | 86K shares | 0.0% | Q1 2026 |
| 88 | RNA | ATRIUM THERAPEUTICS INC | $4.7M | 349.4K shares | 0.0% | Q1 2026 |
| 89 | MOH | MOLINA HEALTHCARE INC | $4.7M | 35K shares | 0.0% | Q1 2026 |
| 90 | IRD | OPUS GENETICS INC | $4.5M | 1M shares | 0.0% | Q1 2026 |
| 91 | TENB | TENABLE HOLDINGS INC | $4.5M | 265K shares | 0.0% | Q1 2026 |
| 92 | PRME | PRIME MEDICINE INC | $4.3M | 1.2M shares | 0.0% | Q1 2024 |
| 93 | SMC | SUMMIT MIDSTREAM CORP | $1.8M | 58.2K shares | 0.0% | Q3 2024 |
| 94 | MDGL | MADRIGAL PHARMACEUTICALS INC | $1.7M | 3.3K shares | 0.0% | before Q2 2023 |
| 95 | CAPR | CAPRICOR THERAPEUTICS INC | $1.2M | 41K shares | 0.0% | Q4 2024 |
| 96 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $991K | 15.8K shares | 0.0% | before Q2 2023 |
| 97 | ANNAW | ALEANNA INC | $802K | 990K shares | 0.0% | Q4 2024 |
| 98 | GH | GUARDANT HEALTH INC | $739K | 8K shares | 0.0% | Q2 2025 |
| 99 | ALKS | ALKERMES PLC | $735K | 20.8K shares | 0.0% | Q1 2025 |
| 100 | ALVO | ALVOTECH SA | $685K | 199.7K shares | 0.0% | before Q2 2023 |
| 101 | AXSM | AXSOME THERAPEUTICS INC | $676K | 4K shares | 0.0% | before Q2 2023 |
| 102 | COGT | COGENT BIOSCIENCES INC | $654K | 17K shares | 0.0% | before Q2 2023 |
| 103 | ANNA | ALEANNA INC | $650K | 78.4K shares | 0.0% | Q4 2024 |
| 104 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $613K | 26K shares | 0.0% | Q1 2024 |
| 105 | CELC | CELCUITY INC | $457K | 4K shares | 0.0% | Q4 2025 |
| 106 | LIVN | LIVANOVA PLC | $381K | 6K shares | 0.0% | Q1 2025 |
| 107 | CUSIP:880881107 | TERNS PHARMACEUTICALS INC | $369K | 7K shares | 0.0% | Q4 2025 |
| 108 | IONS | IONIS PHARMACEUTICALS INC | $360K | 4.8K shares | 0.0% | before Q2 2023 |
| 109 | TVTX | TRAVERE THERAPEUTICS INC | $357K | 12K shares | 0.0% | Q3 2023 |
| 110 | GMED | GLOBUS MEDICAL INC - A | $345K | 4K shares | 0.0% | Q2 2024 |
| 111 | SRRK | SCHOLAR ROCK HOLDING CORP | $344K | 7K shares | 0.0% | Q4 2024 |
| 112 | ONC | BEONE MEDICINES LTD-ADR | $327K | 1.1K shares | 0.0% | Q3 2024 |
| 113 | WGS | GENEDX HOLDINGS CORP | $321K | 5K shares | 0.0% | Q4 2024 |
| 114 | COR | CENCORA INC | $314K | 1K shares | 0.0% | Q4 2023 |
| 115 | NUVL | NUVALENT INC-A | $307K | 3K shares | 0.0% | Q3 2024 |
| 116 | PGNY | PROGYNY INC | $306K | 18K shares | 0.0% | Q1 2024 |
| 117 | STOK | STOKE THERAPEUTICS INC | $293K | 9K shares | 0.0% | Q4 2025 |
| 118 | ERAS | ERASCA INC | $291K | 18K shares | 0.0% | Q1 2026 |
| 119 | EHC | ENCOMPASS HEALTH CORP | $290K | 3K shares | 0.0% | before Q2 2023 |
| 120 | NKTR | NEKTAR THERAPEUTICS | $288K | 4K shares | 0.0% | Q3 2025 |
| 121 | GKOS | GLAUKOS CORP | $280K | 2.6K shares | 0.0% | Q4 2023 |
| 122 | MIRM | MIRUM PHARMACEUTICALS INC | $277K | 3K shares | 0.0% | Q3 2025 |
| 123 | SBRA | SABRA HEALTH CARE REIT INC | $269K | 14K shares | 0.0% | Q4 2023 |
| 124 | KRYS | KRYSTAL BIOTECH INC | $258K | 1K shares | 0.0% | Q3 2023 |
| 125 | OMER | OMEROS CORP | $243K | 23K shares | 0.0% | Q4 2025 |
| 126 | ALMS | ALUMIS INC | $242K | 11K shares | 0.0% | Q1 2026 |
| 127 | CUSIP:03753U106 | APELLIS PHARMACEUTICALS INC | $241K | 6K shares | 0.0% | before Q2 2023 |
| 128 | HQY | HEALTHEQUITY INC | $234K | 2.8K shares | 0.0% | Q3 2023 |
| 129 | SNDX | SYNDAX PHARMACEUTICALS INC | $234K | 10K shares | 0.0% | Q4 2023 |
| 130 | CUSIP:03152W109 | Amicus Therapeutics Inc | $231K | 16K shares | 0.0% | Q3 2023 |
| 131 | QURE | UNIQURE NV | $229K | 14K shares | 0.0% | Q1 2025 |
| 132 | BCRX | BIOCRYST PHARMACEUTICALS INC | $228K | 24K shares | 0.0% | Q3 2025 |
| 133 | VCYT | VERACYTE INC | $225K | 7K shares | 0.0% | Q3 2025 |
| 134 | GRFS | GRIFOLS SA-ADR | $225K | 28K shares | 0.0% | Q1 2024 |
| 135 | ABVX | ABIVAX SA-ADR | $223K | 2K shares | 0.0% | Q3 2025 |
| 136 | GEHC | GE HEALTHCARE TECHNOLOGY | $214K | 3K shares | 0.0% | Q4 2024 |
| 137 | RVMDW | REVOLUTION MEDICINES INC-28 | $209K | 120.1K shares | 0.0% | Q4 2023 |
| 138 | HIMS | HIMS & HERS HEALTH INC | $208K | 10K shares | 0.0% | Q3 2023 |
| 139 | BLTE | BELITE BIO INC - ADR | $207K | 1.3K shares | 0.0% | Q1 2026 |
| 140 | MMSI | MERIT MEDICAL SYSTEMS INC | $207K | 3K shares | 0.0% | Q1 2024 |
| 141 | SUPN | SUPERNUS PHARMACEUTICALS INC | $207K | 4K shares | 0.0% | Q1 2026 |
| 142 | HR | HEALTHCARE REALTY TRUST INC | $204K | 12K shares | 0.0% | Q3 2024 |
| 143 | URGN | UROGEN PHARMA LTD | $198K | 11K shares | 0.0% | Q3 2025 |
| 144 | VIR | VIR BIOTECHNOLOGY INC | $197K | 22K shares | 0.0% | Q1 2026 |
| 145 | PGEN | PRECIGEN INC | $194K | 50K shares | 0.0% | Q4 2025 |
| 146 | SDGR | SCHRODINGER INC | $193K | 17K shares | 0.0% | Q2 2025 |
| 147 | DYN | DYNE THERAPEUTICS INC | $181K | 10K shares | 0.0% | Q2 2024 |
| 148 | NVAX | NOVAVAX INC | $179K | 22K shares | 0.0% | Q1 2024 |
| 149 | PACB | PACIFIC BIOSCIENCES OF CALIF | $178K | 135K shares | 0.0% | before Q2 2023 |
| 150 | SLS | SELLAS LIFE SCIENCES GROUP I | $169K | 40K shares | 0.0% | Q1 2026 |
| 151 | ADPT | ADAPTIVE BIOTECHNOLOGIES | $153K | 11K shares | 0.0% | Q4 2025 |
| 152 | OCUL | OCULAR THERAPEUTIX INC | $152K | 18K shares | 0.0% | Q4 2025 |
| 153 | NEO | NEOGENOMICS INC | $141K | 19K shares | 0.0% | Q4 2025 |
| 154 | ARDX | ARDELYX INC | $138K | 23K shares | 0.0% | Q1 2024 |
| 155 | OSCR | OSCAR HEALTH INC - CLASS A | $126K | 11K shares | 0.0% | Q1 2024 |
| 156 | NUVB | NUVATION BIO INC | $124K | 29K shares | 0.0% | Q4 2025 |
| 157 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $91K | 26K shares | 0.0% | Q4 2023 |
| 158 | SLDPW | DECARBONIZATION PLUS -CW23 | $88K | 405.3K shares | 0.0% | before Q2 2023 |
| 159 | ALT | ALTIMMUNE INC | $85K | 27.6K shares | 0.0% | Q4 2023 |
| 160 | CCCC | C4 THERAPEUTICS INC | $74K | 28K shares | 0.0% | Q1 2024 |
| 161 | TVRD | TVARDI THERAPEUTICS INC | $68K | 21.4K shares | 0.0% | Q2 2025 |
| 162 | GERN | GERON CORP | $64K | 43K shares | 0.0% | Q1 2024 |
| 163 | BGLWW | BLUE GOLD LTD | $60K | 300K shares | 0.0% | Q3 2025 |
| 164 | RANI | RANI THERAPEUTICS HOLDINGS-A | $57K | 78K shares | 0.0% | Q4 2025 |
| 165 | IRWD | IRONWOOD PHARMACEUTICALS INC | $46K | 13K shares | 0.0% | Q1 2024 |
| 166 | EVH | EVOLENT HEALTH INC - A | $32K | 14K shares | 0.0% | before Q2 2023 |
| 167 | CGC | CANOPY GROWTH CORP | $28K | 30K shares | 0.0% | Q2 2024 |
| 168 | NVNIW | NVNI GROUP LTD-28 | $18K | 375K shares | 0.0% | Q4 2023 |
| 169 | BYND | BEYOND MEAT INC | $13K | 19K shares | 0.0% | Q1 2024 |
